BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10387384)

  • 1. The role of resource allocation models in selecting clinical preventive services.
    Wang LY; Haddix AC; Teutsch SM; Caldwell B
    Am J Manag Care; 1999 Apr; 5(4):445-54. PubMed ID: 10387384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive care in managed care and fee-for-service plans: is it cost effective?
    Wang YR; Pauly MV
    Manag Care Interface; 2003 Feb; 16(2):47-50. PubMed ID: 12647527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis and policy choices: investing in health systems.
    Murray CJ; Kreuser J; Whang W
    Bull World Health Organ; 1994; 72(4):663-74. PubMed ID: 7923545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.
    Solberg LI; Maciosek MV; Edwards NM; Khanchandani HS; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):62-71. PubMed ID: 16777544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflective choice in health care: using information technology to present allocation options.
    Rai AK
    Am J Law Med; 1999; 25(2-3):387-402. PubMed ID: 10476335
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
    Marchetti M; Caruggi M; Colombo G
    Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care and efficient rationing.
    Rosenthal MB; Newhouse JP
    J Health Care Finance; 2002; 28(4):1-10. PubMed ID: 12148660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct and indirect effects of cost-sharing on the use of preventive services.
    Solanki G; Schauffler HH; Miller LS
    Health Serv Res; 2000 Feb; 34(6):1331-50. PubMed ID: 10654834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of cardiovascular disease prevention: a graded list as aid to the rational distribution of resources].
    Lindholm L; Hallgren CG; Boman K; Markgren K; Weinehall L; Ogren JE
    Lakartidningen; 1999 Jun; 96(23):2858-63, 2865-6. PubMed ID: 10405534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramsey waits: allocating public health service resources when there is rationing by waiting.
    Gravelle H; Siciliani L
    J Health Econ; 2008 Sep; 27(5):1143-54. PubMed ID: 18468707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision makers' views on health care objectives and budget constraints: results from a pilot study.
    Al MJ; Feenstra T; Brouwer WB
    Health Policy; 2004 Oct; 70(1):33-48. PubMed ID: 15312708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource use and associated care effectiveness results for people with diabetes in managed care organizations.
    Roski J; Turbyville S; Dunn D; Krushat M; Scholle SH
    Am J Med Qual; 2008; 23(5):365-74. PubMed ID: 18820141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis in a setting of budget constraints--is it equitable?
    Ubel PA; DeKay ML; Baron J; Asch DA
    N Engl J Med; 1996 May; 334(18):1174-7. PubMed ID: 8602185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based guidelines, time-based health outcomes, and the Matthew effect.
    Essink-Bot ML; Kruijshaar ME; Barendregt JJ; Bonneux LG
    Eur J Public Health; 2007 Jun; 17(3):314-7. PubMed ID: 17060334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To manage or to be managed: that is the question.
    Kissick WL
    Health Care Manag; 1995 Oct; 2(1):89-100. PubMed ID: 10165646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.